{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:39:43Z","timestamp":1791409183715,"version":"4.3.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,6,13]],"date-time":"2007-06-13T00:00:00Z","timestamp":1181692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1038\/sj.npp.1301472","type":"journal-article","created":{"date-parts":[[2007,6,14]],"date-time":"2007-06-14T05:29:25Z","timestamp":1181798965000},"page":"761-768","source":"Crossref","is-referenced-by-count":143,"title":["Smoked Cocaine Self-Administration is Decreased by Modafinil"],"prefix":"10.1038","volume":"33","author":[{"given":"Carl L","family":"Hart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Haney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne K","family":"Vosburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W","family":"Foltin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,13]]},"reference":[{"key":"BF1301472_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00005053-199403000-00004","volume":"182","author":"IO Arndt","year":"1994","unstructured":"Arndt IO, McLellan AT, Dorozynsky L, Woody GE, O'Brien CP (1994). Desipramine treatment for cocaine dependence. Role of antisocial personality disorder. J Nerv Ment Dis 182: 151\u2013156.","journal-title":"J Nerv Ment Dis"},{"key":"BF1301472_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.30","volume":"12","author":"MT Bardo","year":"1998","unstructured":"Bardo MT (1998). Neuropharmacological mechanisms of the drug reward: beyond dopamine in the nucleus. Crit Rev Neurobiol 12: 37\u201367.","journal-title":"Crit Rev Neurobiol"},{"key":"BF1301472_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.drugalcdep.2005.07.009","volume":"81","author":"A Bisaga","year":"2006","unstructured":"Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN et al (2006). A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend 81: 267\u2013274.","journal-title":"Drug Alcohol Depend"},{"key":"BF1301472_CR4","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1523\/JNEUROSCI.14-11-06763.1994","volume":"14","author":"DL Cameron","year":"1994","unstructured":"Cameron DL, Williams JT (1994). Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J Neurosci 14: 6763\u20136767.","journal-title":"J Neurosci"},{"key":"BF1301472_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1521-0391.2003.tb00610.x","volume":"12","author":"J Campbell","year":"2003","unstructured":"Campbell J, Nickel EJ, Penick EC, Wallace D, Gabrielli WF, Rowe C et al (2003). Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients. Am J Addict 12: 122\u2013136.","journal-title":"Am J Addict"},{"key":"BF1301472_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/sj.npp.1300600","volume":"30","author":"CA Dackis","year":"2005","unstructured":"Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP (2005). A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30: 205\u2013211.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301472_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0376-8716(02)00335-6","volume":"70","author":"CA Dackis","year":"2003","unstructured":"Dackis CA, Lynch KG, Yu E, Samaha FF, Kampman KM, Cornish JW et al (2003). Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend 70: 29\u201337.","journal-title":"Drug Alcohol Depend"},{"key":"BF1301472_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0014-2999(90)90591-S","volume":"180","author":"J Duteil","year":"1990","unstructured":"Duteil J, Rambert FA, Pessonnier J, Hermant JF, Gombert R, Assous E (1990). Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur J Pharmacol 180: 49\u201358.","journal-title":"Eur J Pharmacol"},{"key":"BF1301472_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/sj.npp.1300887","volume":"31","author":"SM Evans","year":"2006","unstructured":"Evans SM, Foltin RW (2006). Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 31: 659\u2013674.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301472_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00213-001-0944-7","volume":"159","author":"SM Evans","year":"2002","unstructured":"Evans SM, Haney M, Foltin RW (2002). The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology 159: 397\u2013406.","journal-title":"Psychopharmacology"},{"key":"BF1301472_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0006-3223(97)00353-3","volume":"42","author":"L Ferraro","year":"1997","unstructured":"Ferraro L, Antonelli T, O'Conner WJ, Tanganelli S, Rambert FA, Fuxe K (1997a). Modafinil: an antinarcoleptic drug with a different neurochemical profile to D-amphetamine and dopamine uptake blockers. Biol Psychiatry 42: 1181\u20131183.","journal-title":"Biol Psychiatry"},{"key":"BF1301472_CR12","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1097\/00001756-199709080-00016","volume":"8","author":"L Ferraro","year":"1997","unstructured":"Ferraro L, Antonelli T, O'Connor WT, Tanganelli S, Rambert F, Fuxe K (1997b). The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus. Neuroreport 8: 2883\u20132887.","journal-title":"Neuroreport"},{"key":"BF1301472_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0893-133X(98)00085-2","volume":"20","author":"L Ferraro","year":"1999","unstructured":"Ferraro L, Antonelli T, Tanganelli S, O'Connor WT, Perez de la Mora M, Mendez-Franco J et al (1999). The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology 20: 346\u2013356.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301472_CR14","first-page":"760","volume":"253","author":"MW Fischman","year":"1990","unstructured":"Fischman MW, Foltin RW, Nestadt G, Pearlson GD (1990). Effects of desipramine maintenance on cocaine self-administration by humans. J Pharmacol Exp Ther 253: 760\u2013770.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1301472_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0376-8716(90)90121-T","volume":"26","author":"RW Foltin","year":"1990","unstructured":"Foltin RW, Fischman MW, Nestadt G, Stromberger H, Cornell EE, Pearlson GD (1990). Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend 26: 145\u2013154.","journal-title":"Drug Alcohol Depend"},{"key":"BF1301472_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pbb.2004.02.018","volume":"78","author":"RW Foltin","year":"2004","unstructured":"Foltin RW, Haney M (2004). Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects. Pharmacol Biochem Behav 78: 93\u2013101.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1301472_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1037\/1064-1297.11.2.123","volume":"11","author":"RW Foltin","year":"2003","unstructured":"Foltin RW, Ward AS, Collins ED, Haney M, Hart CL, Fischman MW (2003). The effects of venlafaxine on the subjective, reinforcing and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans. Exp Clin Psychopharmacol 11: 123\u2013130.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BF1301472_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s002130050925","volume":"143","author":"M Haney","year":"1999","unstructured":"Haney M, Collins ED, Ward AS, Foltin RW, Fischman MW (1999). Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology 143: 102\u2013110.","journal-title":"Psychopharmacology"},{"key":"BF1301472_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.drugalcdep.2006.05.028","volume":"86","author":"CL Hart","year":"2007","unstructured":"Hart CL, Haney M, Collins ED, Rubin E, Foltin RW (2007a). Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses. Drug Alcohol Depend 86: 274\u2013277.","journal-title":"Drug Alcohol Depend"},{"key":"BF1301472_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/FBP.0b013e328014139d","volume":"18","author":"CL Hart","year":"2007","unstructured":"Hart CL, Haney M, Vosburg SK, Rubin E, Foltin RW (2007b). Gabapentin does not reduce smoked cocaine self-administration: employment of a novel self-administration procedure. Behav Pharmacol 18: 71\u201375.","journal-title":"Behav Pharmacol"},{"key":"BF1301472_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1570159053586726","volume":"3","author":"CL Hart","year":"2005","unstructured":"Hart CL, Lynch WJ (2005). Developing pharmacotherapies for cannabis and cocaine use disorders. Curr Neuropharmacol 3: 95\u2013114.","journal-title":"Curr Neuropharmacol"},{"key":"BF1301472_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.drugalcdep.2003.10.015","volume":"73","author":"CL Hart","year":"2004","unstructured":"Hart CL, Ward AS, Collins ED, Haney M, Foltin RW (2004). Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend 73: 279\u2013287.","journal-title":"Drug Alcohol Depend"},{"key":"BF1301472_CR23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1177\/00912700122010690","volume":"41","author":"ET Hellriegel","year":"2001","unstructured":"Hellriegel ET, Arora S, Nelson M, Robertson P (2001). Steady-state pharmacokinetics and tolerability of modafinil given alone or in combination with methylphenidate in healthy volunteers. J Clin Pharmacol 41: 895\u2013904.","journal-title":"J Clin Pharmacol"},{"key":"BF1301472_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/jat\/16.5.311","volume":"16","author":"DS Isenschmid","year":"1992","unstructured":"Isenschmid DS, Fischman MW, Foltin RW, Caplan YH (1992). Concentration of cocaine and metabolites in plasma of humans following intravenous administration and smoking of cocaine. J Anal Toxicol 16: 311\u2013314.","journal-title":"J Anal Toxicol"},{"key":"BF1301472_CR25","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.neuropharm.2006.09.005","volume":"52","author":"TM Korotkova","year":"2007","unstructured":"Korotkova TM, Klyuch BP, Ponomarenko AA, Lin JS, Haas HL, Sergeeva OA (2007). Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors. Neuropharmacology 52: 626\u2013633.","journal-title":"Neuropharmacology"},{"key":"BF1301472_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0006-8993(92)91713-O","volume":"591","author":"JS Lin","year":"1992","unstructured":"Lin JS, Roussel B, Akaoka H, Fort P, Debilly G, Jouvet M (1992). Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 591: 319\u2013326.","journal-title":"Brain Res"},{"key":"BF1301472_CR27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1124\/jpet.106.106583","volume":"319","author":"BK Madras","year":"2006","unstructured":"Madras BK, Xie Z, Lin Z, Panas H, Lynch L, Johnson R et al (2006). Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 319: 561\u2013569.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1301472_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/00952990600920425","volume":"32","author":"R Malcolm","year":"2006","unstructured":"Malcolm R, Swayngim K, Donovan JL, Devane CL, Elkashef A, Chiang N et al (2006). Modafinil and cocaine interactions. Am J Drug Alcohol Abuse 32: 577\u2013587.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BF1301472_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.drugalcdep.2005.03.026","volume":"80","author":"D McDowell","year":"2005","unstructured":"McDowell D, Nunes EV, Seracini AM, Rothenberg J, Vosburg SK, Ma GJ et al (2005). Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. Drug Alcohol Depend 80: 209\u2013221.","journal-title":"Drug Alcohol Depend"},{"key":"BF1301472_CR30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/sleep\/17.5.436","volume":"17","author":"E Mignot","year":"1994","unstructured":"Mignot E, Nishino S, Guilleminault C, Dement WC (1994). Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 17: 436\u2013437.","journal-title":"Sleep"},{"key":"BF1301472_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/(SICI)1098-2396(199710)27:2<95::AID-SYN1>3.0.CO;2-6","volume":"27","author":"MS Reid","year":"1997","unstructured":"Reid MS, Hsu Jr K, Berger SP (1997). Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse 27: 95\u2013105.","journal-title":"Synapse"},{"key":"BF1301472_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1517\/14728214.11.1.91","volume":"11","author":"M Sofuoglu","year":"2006","unstructured":"Sofuoglu M, Kosten TR (2006). Emerging pharmacological strategies in the flight against cocaine addiction. Expert Opin Emerg Drugs 11: 91\u201398.","journal-title":"Expert Opin Emerg Drugs"},{"key":"BF1301472_CR33","unstructured":"Substance Abuse and Mental Health Services Administration, Office of Applied Studies (2006). Treatment Episode Data Set (TEDS). Highlights\u20142005. National Admissions to Substance Abuse Treatment Services, DASIS Series: S-36, DHHS Publication No. (SMA) 07-4229, Rockville, MD."},{"key":"BF1301472_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2005.06.010","volume":"108","author":"F Vocci","year":"2005","unstructured":"Vocci F, Ling W (2005). Medications development: successes and challenges. Pharmacol Ther 108: 94\u2013108.","journal-title":"Pharmacol Ther"},{"key":"BF1301472_CR35","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.neuroscience.2005.02.003","volume":"132","author":"JP Wisor","year":"2005","unstructured":"Wisor JP, Eriksson KS (2005). Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 132: 1027\u20131034.","journal-title":"Neuroscience"},{"key":"BF1301472_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/00912709922007534","volume":"39","author":"YN Wong","year":"1999","unstructured":"Wong YN, Simcoe D, Hartman LN, Laughton WB, King SP, McCormick GC et al (1999). A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 39: 30\u201340.","journal-title":"J Clin Pharmacol"},{"key":"BF1301472_CR37","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/j.1552-4604.1998.tb04395.x","volume":"38","author":"YN Wong","year":"1998","unstructured":"Wong YN, Wang L, Hartman L, Simcoe D, Chen Y, Laughton W et al (1998). Comparison of the single-dose pharmacokinetics and tolerability of modafinil and dextroamphetamine administered alone or in combination in healthy male volunteers. J Clin Pharmacol 38: 971\u2013978.","journal-title":"J Clin Pharmacol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1301472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301472","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:55:34Z","timestamp":1684220134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1301472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,13]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["BF1301472"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1301472","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,13]]}}}